Dosimetric characteristics of the Pharma Seed™ model BT-125-I source-Reference-Cited by-同舟云学术

Dosimetric characteristics of the Pharma Seed™ model BT-125-I source

Published:2000-09 Issue:9 Volume:27 Page:2174-2181
ISSN:0094-2405
Container-title:Medical Physics
language:en
Short-container-title:Med. Phys.

Author:

Popescu C. C.,Wise J.,Sowards K.,Meigooni A. S.,Ibbott G. S.

Publisher

Wiley

Subject

General Medicine

Reference22 articles.

1. Recent advances in interstitial brachytherapy for localized prostate cancer;Russell;Probl. Urology,1993

2. Conformal brachytherapy of prostate cancer: An effective out-patient treatment;Nori;Cancer Watch,1992

3. Permanent interstitial implantation using paladium-103: The New York Medical College preliminary experience;Porrazzo;Int. J. Radiat. Oncol., Biol., Phys.,1992

4. Prostate specific antigen based control following ultrasound guided 125I implantation for Stage T1/T2 Prostate carcinoma;Blasko;J. Urol. (Baltimore),1995

5. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43;Nath;Med. Phys.,1995

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the dosimetric parameters of 125I BEBIG IsoSeed® I25.S06 source: GATE 8.2 Monte Carlo code;Applied Radiation and Isotopes;2022-08

2. Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer;Pancreas;2021-07

3. Design and fabrication of 125I seeds for brachytherapy using capillary-based microfluidic technique;Nukleonika;2021-06-01

4. Update of the CLRP TG‐43 parameter database for low‐energy brachytherapy sources;Medical Physics;2020-07-13

5. Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with 125I seeds intracavitary irradiation;Clinical and Translational Oncology;2018-10-27